(CGAU) Centerra Gold - Overview
Sector: Basic Materials | Industry: Gold | Exchange: NYSE (USA) | Market Cap: 3.902m USD | Total Return: 198.6% in 12m
Industry Rotation: +4.3
Avg Turnover: 30.2M USD
Peers RS (IBD): 93.0
EPS Trend: 69.1%
Qual. Beats: 3
Rev. Trend: 70.8%
Qual. Beats: 0
Warnings
Choppy
Tailwinds
No distinct edge detected
Centerra Gold Inc. (CGAU) is a Canadian company operating in the diversified metals and mining sector. It focuses on the operation, development, exploration, and acquisition of gold and copper properties across North America, Turkey, and other international locations.
The company also manages a molybdenum business unit, which includes a processing facility and two primary molybdenum properties. Molybdenum is a key metal used in high-strength alloys and chemical applications.
Key assets include the Mount Milligan gold-copper mine and the Kemess project in British Columbia, Canada; the Öksüt gold mine in Turkey; the Goldfield District project in Nevada, USA; the Thompson Creek Mine in Idaho; and a 75% stake in the Endako Mine in British Columbia, Canada. Mining companies often diversify their asset portfolios geographically to mitigate geopolitical and operational risks.
For more detailed operational and financial data, consider exploring its profile on ValueRay.
- Gold and copper price fluctuations impact revenue
- Production costs at Mount Milligan mine affect profitability
- Regulatory changes in Turkey pose operational risks
- Molybdenum business unit performance diversifies revenue streams
| Net Income: 587.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -2.92 > 1.0 |
| NWC/Revenue: 45.76% < 20% (prev 58.39%; Δ -12.63% < -1%) |
| CFO/TA 0.12 > 3% & CFO 349.3m > Net Income 587.0m |
| Net Debt (-498.4m) to EBITDA (861.6m): -0.58 < 3 |
| Current Ratio: 2.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (204.0m) vs 12m ago -2.85% < -2% |
| Gross Margin: 30.78% > 18% (prev 0.33%; Δ 3.04k% > 0.5%) |
| Asset Turnover: 52.23% > 50% (prev 53.62%; Δ -1.39% > 0%) |
| Interest Coverage Ratio: 49.59 > 6 (EBITDA TTM 861.6m / Interest Expense TTM 15.1m) |
| A: 0.21 (Total Current Assets 1.07b - Total Current Liabilities 446.1m) / Total Assets 2.94b |
| B: 0.46 (Retained Earnings 1.35b / Total Assets 2.94b) |
| C: 0.29 (EBIT TTM 750.1m / Avg Total Assets 2.60b) |
| D: 2.29 (Book Value of Equity 2.03b / Total Liabilities 884.3m) |
| Altman-Z'' Score: 7.22 = AAA |
| DSRI: 1.63 (Receivables 137.3m/75.0m, Revenue 1.36b/1.21b) |
| GMI: 1.08 (GM 30.78% / 33.36%) |
| AQI: 1.24 (AQ_t 0.09 / AQ_t-1 0.08) |
| SGI: 1.12 (Revenue 1.36b / 1.21b) |
| TATA: 0.08 (NI 587.0m - CFO 349.3m) / TA 2.94b) |
| Beneish M-Score: -2.12 (Cap -4..+1) = BB |
Over the past week, the price has changed by +6.40%, over one month by +8.26%, over three months by +24.34% and over the past year by +198.59%.
- StrongBuy: 3
- Buy: 5
- Hold: 2
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 16.8 | -15.4% |
P/E Forward = 8.5911
P/S = 2.8186
P/B = 1.8856
Revenue TTM = 1.36b USD
EBIT TTM = 750.1m USD
EBITDA TTM = 861.6m USD
Long Term Debt = 18.8m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 7.91m USD (from shortTermDebt, last quarter)
Debt = 29.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -498.4m USD (from netDebt column, last quarter)
Enterprise Value = 3.39b USD (3.90b + Debt 29.6m - CCE 539.9m)
Interest Coverage Ratio = 49.59 (Ebit TTM 750.1m / Interest Expense TTM 15.1m)
EV/FCF = 36.03x (Enterprise Value 3.39b / FCF TTM 94.1m)
FCF Yield = 2.78% (FCF TTM 94.1m / Enterprise Value 3.39b)
FCF Margin = 6.93% (FCF TTM 94.1m / Revenue TTM 1.36b)
Net Margin = 43.18% (Net Income TTM 587.0m / Revenue TTM 1.36b)
Gross Margin = 30.78% ((Revenue TTM 1.36b - Cost of Revenue TTM 941.0m) / Revenue TTM)
Gross Margin QoQ = 31.35% (prev 34.53%)
Tobins Q-Ratio = 1.15 (Enterprise Value 3.39b / Total Assets 2.94b)
Interest Expense / Debt = 14.13% (Interest Expense 4.18m / Debt 29.6m)
Taxrate = 25.15% (65.8m / 261.5m)
NOPAT = 561.4m (EBIT 750.1m * (1 - 25.15%))
Current Ratio = 2.39 (Total Current Assets 1.07b / Total Current Liabilities 446.1m)
Debt / Equity = 0.01 (Debt 29.6m / totalStockholderEquity, last quarter 2.06b)
Debt / EBITDA = -0.58 (Net Debt -498.4m / EBITDA 861.6m)
Debt / FCF = -5.29 (Net Debt -498.4m / FCF TTM 94.1m)
Total Stockholder Equity = 1.84b (last 4 quarters mean from totalStockholderEquity)
RoA = 22.55% (Net Income 587.0m / Total Assets 2.94b)
RoE = 31.90% (Net Income TTM 587.0m / Total Stockholder Equity 1.84b)
RoCE = 40.36% (EBIT 750.1m / Capital Employed (Equity 1.84b + L.T.Debt 18.8m))
RoIC = 30.50% (NOPAT 561.4m / Invested Capital 1.84b)
WACC = 8.76% (E(3.90b)/V(3.93b) * Re(8.75%) + D(29.6m)/V(3.93b) * Rd(14.13%) * (1-Tc(0.25)))
Discount Rate = 8.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.70%
[DCF] Terminal Value 67.26% ; FCFF base≈111.9m ; Y1≈73.5m ; Y5≈33.6m
[DCF] Fair Price = 5.44 (EV 586.6m - Net Debt -498.4m = Equity 1.08b / Shares 199.6m; r=8.76% [WACC]; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 69.14 | EPS CAGR: 22.77% | SUE: 1.70 | # QB: 3
Revenue Correlation: 70.83 | Revenue CAGR: 6.69% | SUE: -0.30 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.51 | Chg7d=-0.031 | Chg30d=+0.019 | Revisions Net=+3 | Analysts=5
EPS current Year (2026-12-31): EPS=2.16 | Chg7d=+0.109 | Chg30d=+0.268 | Revisions Net=+5 | Growth EPS=+94.4% | Growth Revenue=+18.1%
EPS next Year (2027-12-31): EPS=2.07 | Chg7d=-0.087 | Chg30d=+0.097 | Revisions Net=+1 | Growth EPS=-4.3% | Growth Revenue=+17.6%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -5.8% (Discount Rate 8.8% - Earnings Yield 14.6%)
[Growth] Growth Spread = +21.4% (Analyst 15.6% - Implied -5.8%)